Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$8.23 - $13.93 $707 - $1,197
-86 Reduced 52.76%
77 $0
Q1 2023

May 10, 2023

SELL
$7.94 - $12.02 $452 - $685
-57 Reduced 25.91%
163 $1,000
Q4 2022

Feb 08, 2023

BUY
$5.67 - $11.2 $759 - $1,500
134 Added 155.81%
220 $1,000
Q3 2022

Nov 09, 2022

BUY
$3.93 - $8.57 $337 - $737
86 New
86 $0
Q2 2022

Aug 12, 2022

SELL
$4.02 - $10.43 $96 - $250
-24 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$19.26 - $30.08 $462 - $721
24 New
24 $0

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.